Skip to Main Content

Paper Details

Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
medRxiv
0
2023
CCP, COVID, COVID-19, SARS-CoV, SARS-CoV-2 antibody, immunocompromised
Author NameAffiliation
Aarthi ShenoyMedStar Washington Hospital Center
Janis E BlairMayo Clinic Hospital
Judith S CurrierUniversity of California los angeles
Judith S CurrierUniversity of California los angeles
Martin S ZandUniversity of Rochester Medical Center
Jay S RavalUniversity of New Mexico School of Medicine
Daniel E FordInstitute for Clinical and Translational Research Johns Hopkins University School of Medicine
Douglas A JabsDepartment of Ophthalmology Johns Hopkins University School of Medicine
Bryan LauJohns Hopkins Bloomberg School of Public Health
Arturo CasadevallW. Harry Feinstone Department of Molecular Microbiology and Immunology Johns Hopkins Bloomberg School of Public Health
Arturo CasadevallW. Harry Feinstone Department of Molecular Microbiology and Immunology Johns Hopkins Bloomberg School of Public Health
Shmuel ShohamJohns Hopkins University School of Medicine
Evan M BlochJohns Hopkins University School of Medicine
Kelly A GeboJohns Hopkins University School of Medicine
Aaron A R TobianJohns Hopkins University School of Medicine
Oliver LaeyendeckerNational Institute of Allergy and Infectious Diseases
Andrew PekoszW. Harry Feinstone Department of Molecular Microbiology and Immunology Johns Hopkins Bloomberg School of Public Health
  • 1 - 17

Datasets